1-1 of 1
Chuke Nwachuku, MA, MPH, DRPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Henry R. Black, MD, Barry Davis, MD, PHD, Joshua Barzilay, MD, Chuke Nwachuku, MA, MPH, DRPH, Charles Baimbridge, MS, Horia Marginean, MD, MS, Jackson T. Wright, Jr., MD, PHD, Jan Basile, MD, Nathan D. Wong, PHD, Paul Whelton, MD, MSC, Richard A. Dart, MD, Udho Thadani, MD
Journal: Diabetes Care
Diabetes Care 2008;31(2):353–360
https://doi.org/10.2337/dc07-1452
Published: 01 February 2008
View article titled, Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension: <subtitle>A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)</subtitle>
Open the PDF for Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension: <subtitle>A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)</subtitle> in another window
Includes: Supplementary data